Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001786869 | SCV002028833 | uncertain significance | not provided | 2021-05-25 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29482223) |
Labcorp Genetics |
RCV002541251 | SCV003258990 | uncertain significance | Spastic ataxia 2 | 2022-07-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 997 of the KIF1C protein (p.Gly997Arg). This variant is present in population databases (rs774701979, gnomAD 0.009%). This missense change has been observed in individual(s) with ataxia (PMID: 29482223). ClinVar contains an entry for this variant (Variation ID: 1326689). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. |